‘It felt like finding hope only to lose it again’: A grounded theory study of rare cancer policies in Bulgaria
Open Access
- 11 March 2025
- journal article
- Published by Elsevier in Journal of Cancer Policy
- Vol. 44, 100570
Abstract
No abstract availableKeywords
Funding Information
- National Health Insurance Administration
- Republic of Bulgaria Ministry of Education and Science
This publication has 51 references indexed in Scilit:
- Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and ChallengesApplied Health Economics and Health Policy, 2024
- Challenges and positive impact of rare cancer caregiving: A mixed-methods study of caregivers of patients with Erdheim-Chester disease and other histiocytic neoplasmseClinicalMedicine, 2022
- Shaping national plans and strategies for rare diseases in Europe: past, present, and futureJournal of Community Genetics, 2021
- Inaction and public policy: understanding why policymakers ‘do nothing’Policy Sciences, 2019
- Making surgery safer by centralization of care: impact of case load in penile cancerWorld Journal of Urology, 2019
- Travel burden associated with rare cancers: The example of Merkel cell carcinomaCancer Medicine, 2019
- Drivers, trends and scenarios for the future of health in Europe. Impressions from the FRESHER projectEuropean Journal of Futures Research, 2018
- The history and use of cancer registry data by public health cancer control programs in the United StatesCancer, 2017
- Rare cancers are not so rare: The rare cancer burden in EuropeEuropean Journal of Cancer, 2011
- European multi-centre case–control study on risk factors for rare cancers of unknown aetiologyEuropean Journal of Cancer, 2005